The Centers for Medicare & Medicaid Services (CMS) hosted a webinar titled “Eligible Clinician eCQM Diabetes Measures” on January 30, 2019. This one-hour session provided an in-depth review of the Diabetes electronic clinical quality measures (eCQMs) including: Hemoglobin A1c (HbA1c) Poor Control (greater than 9%) (CMS122), Eye Exam (CMS131), and Medical Attention for Nephropathy (CMS134). CMS has transitioned the logic used in eCQMs from the previous quality data model (QDM) logic expression language to Clinical Quality Language (CQL) for the 2019 performance year. This session provided an introduction to the top reported Diabetes measures and addressed terminology and value set changes for 2019 Merit-based Incentive Payment System (MIPS) Quality performance year. As a result of the feedback received from stakeholders interviewed through the CMS eCQM Strategy Project to reduce implementation and reporting burdens, this session was intended to prepare eligible clinicians, vendors, quality, and health information technology staff for eCQM reporting, and was the third in a series of five educational sessions to provide relevant information to support successful understanding, interpretation, and implementation of eCQMs.
